Biome Australia Ltd (BIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biome Australia Ltd (BIO) has a cash flow conversion efficiency ratio of 0.344x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$2.09 Million ≈ $1.48 Million USD) by net assets (AU$6.06 Million ≈ $4.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Biome Australia Ltd stock valuation for the company's overall valuation and market capitalisation.
Biome Australia Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Biome Australia Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Biome Australia Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biome Australia Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Biome Australia Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Golan Plastic
TA:GLPL
|
0.112x |
|
Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd
KQ:307870
|
-0.030x |
|
3P Learning Ltd
AU:3PL
|
0.087x |
|
Ace Technologies Corp
KQ:088800
|
-0.091x |
|
Ilyda SA
AT:ILYDA
|
0.013x |
|
Woosu AMS Co.Ltd
KQ:066590
|
-0.071x |
|
Energous Corporation
NASDAQ:WATT
|
-0.132x |
|
Finger Inc.
KQ:163730
|
0.073x |
Annual Cash Flow Conversion Efficiency for Biome Australia Ltd (2019–2025)
The table below shows the annual cash flow conversion efficiency of Biome Australia Ltd from 2019 to 2025. View Biome Australia Ltd (BIO) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$4.68 Million ≈ $3.31 Million |
AU$-2.82 Million ≈ $-2.00 Million |
-0.603x | -969.00% |
| 2024-06-30 | AU$2.90 Million ≈ $2.05 Million |
AU$-163.81K ≈ $-115.90K |
-0.056x | +94.21% |
| 2023-06-30 | AU$3.59 Million ≈ $2.54 Million |
AU$-3.50 Million ≈ $-2.47 Million |
-0.975x | -85.99% |
| 2022-06-30 | AU$6.53 Million ≈ $4.62 Million |
AU$-3.42 Million ≈ $-2.42 Million |
-0.524x | -122.82% |
| 2021-06-30 | AU$10.17 Million ≈ $7.20 Million |
AU$-2.39 Million ≈ $-1.69 Million |
-0.235x | +93.06% |
| 2020-06-30 | AU$949.54K ≈ $671.86K |
AU$-3.22 Million ≈ $-2.28 Million |
-3.392x | -91.64% |
| 2019-06-30 | AU$1.20 Million ≈ $852.36K |
AU$-2.13 Million ≈ $-1.51 Million |
-1.770x | -- |
About Biome Australia Ltd
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and nutraceutical and complementary medicines under the Activated Therapeutics brand. It markets its products through … Read more